CIK 0001619856
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453728228
- Phone
- +1 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-20 | Fischesser Ryan VP of Finance and Controller | Grant or award | +25,000 | 118,854 | ||
| 2022-10-06 | Fischesser Ryan VP of Finance and Controller | Sale | −10,000 | $10.80 | $108K | 110,366 |
| 2022-10-06 | Fischesser Ryan VP of Finance and Controller | Exercise or conversion | +2,839 | $2.69 | $8K | 113,205 |
| 2022-10-06 | Fischesser Ryan VP of Finance and Controller | Exercise or conversion | +2,839 | $4.11 | $12K | 116,044 |
| 2022-10-06 | Fischesser Ryan VP of Finance and Controller | Exercise or conversion · Option to purchase Common Stock | −2,839 | 1,704 | ||
| 2022-10-06 | Fischesser Ryan VP of Finance and Controller | Exercise or conversion · Option to purchase Common Stock | −2,839 | 15,337 | ||
| 2022-08-22 | Fischesser Ryan VP of Finance and Controller | Grant or award | +4,848 | 120,366 | ||
| 2022-05-05 | Fischesser Ryan VP of Finance and Controller | Exercise or conversion | +1,136 | $2.69 | $3K | 114,380 |
| 2022-05-05 | Fischesser Ryan VP of Finance and Controller | Exercise or conversion | +1,138 | $4.11 | $5K | 115,518 |
| 2022-05-05 | Fischesser Ryan VP of Finance and Controller | Exercise or conversion · Option to purchase Common Stock | −1,136 | 4,543 | ||
| 2022-05-05 | Fischesser Ryan VP of Finance and Controller | Exercise or conversion · Option to purchase Common Stock | −1,138 | 18,176 | ||
| 2022-03-15 | Fischesser Ryan VP of Finance and Controller | Exercise or conversion | +1,136 | $2.69 | $3K | 112,106 |
| 2022-03-15 | Fischesser Ryan VP of Finance and Controller | Exercise or conversion | +1,138 | $4.11 | $5K | 113,244 |
| 2022-03-15 | Fischesser Ryan VP of Finance and Controller | Exercise or conversion · Option to purchase Common Stock | −1,136 | 5,679 | ||
| 2022-03-15 | Fischesser Ryan VP of Finance and Controller | Exercise or conversion · Option to purchase Common Stock | −1,138 | 19,314 | ||
| 2022-01-11 | Fischesser Ryan VP of Finance and Controller | Purchase | +569 | $2.69 | $2K | 102,264 |
| 2022-01-11 | Fischesser Ryan VP of Finance and Controller | Purchase | +6,818 | $4.11 | $28K | 109,082 |
| 2022-01-11 | Fischesser Ryan VP of Finance and Controller | Option exercise · Option to purchase Common Stock | −569 | 6,815 | ||
| 2022-01-11 | Fischesser Ryan VP of Finance and Controller | Option exercise · Option to purchase Common Stock | −6,818 | 20,452 | ||
| 2021-12-20 | Fischesser Ryan VP of Finance and Controller | Purchase | +1,136 | $2.69 | $3K | 101,695 |
Page 1 of 2 · 24 trades